Oxford Canabinoid Tech. Complete Phase 1 Clinical Trials on Programme 1 for CIPN Treatment

Video
Written By Rob Bennett

Rob Bennett https://www.octavianrx.com
Previous

Oxford Cannabinoid Technologies reports no adverse events in OCT461201 trial
Next

A pharmaceutical approach to cannabinoids